Abstract:ABSTRACT The use of metagenomic next-generation sequencing technology to obtain complete viral genome sequences directly from clinical samples with low viral load remains challenging—especially in the case of respiratory viruses—due to the low copy number of viral versus host genomes. To overcome this limitation, target capture sequencing for the enrichment of specific genomes has been developed and applied for direct genome sequencing of viruses. However, as the efficiency of enrichment varies depending on the probes, the type of clinical sample, etc., validation is essential before target capture sequencing can be applied to clinical diagnostics. In this study, we evaluated the utility of target capture sequencing with a comprehensive viral probe panel for clinical respiratory specimens collected from patients diagnosed with SARS-CoV-2 or influenza type A. We focused on clinical specimens containing low copy numbers of viral genomes. Target capture sequencing yielded approximately 180- and 2,000-fold higher read counts of SARS-CoV-2 and influenza A virus, respectively, than metagenomic sequencing when the RNA extracted from specimens contained 59.3 copies/μL of SARS-CoV-2 or 625.1 copies/μL of influenza A virus. In addition, the target capture sequencing identified sequence reads in all SARS-CoV-2- or influenza type A-positive specimens with 70% of the full-length genomes of SARS-CoV-2 or influenza A virus. Furthermore, the target capture sequencing using comprehensive probes identified co-infections with viruses other than SARS-CoV-2, suggesting that this approach will not only detect a wide range of viruses but also contribute to epidemiological studies. IMPORTANCE Target capture sequencing has been developed and applied for direct genome sequencing of viruses in clinical specimens to overcome the low detection sensitivity of metagenomic next-generation sequencing. In this study, we evaluated the utility of target capture sequencing with a comprehensive viral probe panel for clinical respiratory specimens collected from patients diagnosed with SARS-CoV-2 or influenza type A, focusing on clinical specimens containing low copy numbers of viral genomes. Our results showed that the target capture sequencing yielded dramatically higher read counts than metagenomic sequencing for both viruses. Furthermore, the target capture sequencing using comprehensive probes identified co-infections with other viruses, suggesting that this approach will not only detect a wide range of viruses but also contribute to epidemiological studies.

Direct next-generation sequencing of virus-human mixed samples without pretreatment is favorable to recover virus genome

Rapid Detection of Potential New Pathogens in Patient Using High -Throughput Sequencing

Rapid Genome Sequencing and Characterization of Novel Avian-Origin Influenza A H7N9 Virus Directly from Clinical Sample by Semiconductor Sequencing.

Application of Next Generation Sequencing Technology on Contamination Monitoring in Microbiology Laboratory

Full Genome of Influenza A (H7N9) Virus Derived by Direct Sequencing Without Culture

Evaluation of the impact of concentration and extraction methods on the targeted sequencing of human viruses from wastewater

The Applications of Nanopore Sequencing Technology in Animal and Human Virus Research

Discriminating Clonotypes of Influenza A Virus Genes by Nanopore Sequencing

A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification

Targeted Virome Sequencing Enhances Unbiased Detection and Genome Assembly of Known and Emerging Viruses—The Example of SARS-CoV-2

Comprehensive viral enrichment enables sensitive respiratory virus genomic identification and analysis by next generation sequencing

MINERVA: A Facile Strategy for SARS-CoV-2 Whole-Genome Deep Sequencing of Clinical Samples

Improved influenza A whole-genome sequencing protocol

Non-target RNA depletion strategy to improve sensitivity of next-generation sequencing for the detection of RNA viruses in poultry

Direct genome sequencing of respiratory viruses from low viral load clinical specimens using the target capture sequencing technology

Direct genome sequencing of respiratory viruses from low viral load clinical specimens using target capture sequencing technology

An Evaluation of Avian Influenza Virus Whole-Genome Sequencing Approaches Using Nanopore Technology

An Amplicon-Based Application for the Whole-Genome Sequencing of GI-19 Lineage Infectious Bronchitis Virus Directly from Clinical Samples

High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing

Unbiased metagenomic detection of RNA viruses for rapid identification of viral pathogens in clinical samples